1. bookVolume 58 (2020): Edizione 1 (March 2020)
Dettagli della rivista
License
Formato
Rivista
eISSN
2501-062X
Prima pubblicazione
30 Mar 2015
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

Comparison between thrombophilic gene polymorphisms among high risk patients

Pubblicato online: 03 Mar 2020
Volume & Edizione: Volume 58 (2020) - Edizione 1 (March 2020)
Pagine: 20 - 26
Ricevuto: 31 Jul 2019
Dettagli della rivista
License
Formato
Rivista
eISSN
2501-062X
Prima pubblicazione
30 Mar 2015
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

1. LANE, D.A., P.M. MANNUCCI, K.A. BAUER, R.M. BERTINA, N.P. BOCHKOV, V. BOULYJNKOV, et al., Inherited thrombophilia: part 1. Thrombosis and haemostasis, 1996. 76(05): p. 651–662.10.1055/s-0038-1650638Search in Google Scholar

2. BUCHHOLZ, T. and C.J. THALER, Inherited thrombophilia: impact on human reproduction. American Journal of Reproductive Immunology, 2003. 50(1): p. 20–32.10.1034/j.1600-0897.2003.00049.x14506925Search in Google Scholar

3. CORIU, L., R. UNGUREANU, R. TALMACI, V. USCATESCU, M. CIRSTOIU, D. CORIU, et al., Hereditary Thrombophilia and thrombotic events in pregnancy: single-center experience. Journal of medicine and life, 2014. 7(4): p. 567.Search in Google Scholar

4. BERTINA, R.M., B.P. KOELEMAN, T. KOSTER, F.R. ROSENDAAL, R.J. DIRVEN, H. DE RONDE, et al., Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 1994. 369(6475): p. 64.Search in Google Scholar

5. RIDKER, P.M., J.P. MILETICH, C.H. HENNEKENS, and J.E. BURING, Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening. Jama, 1997. 277(16): p. 1305–1307.10.1001/jama.1997.03540400055031Search in Google Scholar

6. POORT, S.R., F.R. ROSENDAAL, P.H. REITSMA, and R.M. BERTINA, A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996. 88(10): p. 3698–3703.10.1182/blood.V88.10.3698.bloodjournal88103698Search in Google Scholar

7. ROSENDAAL, F., C.J.M. DOGGEN, A. ZIVELIN, V. ARRUDA, M. AIACH, D. SISCOVICK, et al., Geographic distribution of the 20210 G to A prothrombin variant. Thrombosis and haemostasis, 1998. 79(04): p. 706–708.10.1055/s-0037-1615049Search in Google Scholar

8. BARCELLONA, D., L. FENU, C. CAULI, G. PISU, and F. MARONGIU, Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thrombosis and haemostasis, 2003. 90(12): p. 1061–1064.10.1160/TH02-12-030514652637Search in Google Scholar

9. WILLIAMS, K.T. and K.L. SCHALINSKE, Homocysteine metabolism and its relation to health and disease. Biofactors, 2010. 36(1): p. 19–24.10.1002/biof.7120091801Search in Google Scholar

10. DEN HEIJER, M., S. LEWINGTON, and R. CLARKE, Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. Journal of Thrombosis and Haemostasis, 2005. 3(2): p. 292–299.10.1111/j.1538-7836.2005.01141.x15670035Search in Google Scholar

11. HICKS, L.K., H. BERING, K.R. CARSON, J. KLEINERMAN, V. KUKRETI, A. MA, et al., The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood, 2013. 122(24): p. 3879–3883.10.1182/blood-2013-07-51842324307720Search in Google Scholar

12. CONNORS, J.M., Thrombophilia testing and venous thrombosis. New England Journal of Medicine, 2017. 377(12): p. 1177–1187.10.1056/NEJMra170036528930509Search in Google Scholar

13. SIMIONI, P., Who should be tested for thrombophilia? Current opinion in hematology, 2006. 13(5): p. 337–343.10.1097/01.moh.0000239705.25050.ffSearch in Google Scholar

14. ANTONOV, A., Correlation between Tumor Angiogenesis, Mutation Load, Changes in the Blood Count and the Thrombogenic Risk in Patients with Essential Thrombocythaemia and Polycythaemia Vera///Корелационна зависимост между туморната ангиогенеза, мутационния товар, промените в кръвната картина, и тромбогенния риск при пациенти с есенциална тромбоцитемия и полицитемия вера. 2018, Medical University of Varna.Search in Google Scholar

15. NIKOLOVA-VLAHOVA M., SAVOV AL., BALEVA M. AND KARAGIOZOVA ZH., Hereditary thrombophilic factors and antiphospholipid syndrome. Medicinski pregled, 2019. 55(1): p. 46–52.Search in Google Scholar

16. BENDER ATIK, R., O.B. CHRISTIANSEN, J. ELSON, A.M. KOLTE, S. LEWIS, S. MIDDELDORP, et al., ESHRE guideline: recurrent pregnancy loss. 2018, Oxford University Press DOI: 10.1093/hropen/hoy004.10.1093/hropen/hoy004Search in Google Scholar

17. IVANOV, P.D., R.S. KOMSA-PENKOVA, E.I. KONOVA, K.S. KOVACHEVA, M.N. SIMEONOVA, and J.D. POPOV, Association of inherited thrombophilia with embryonic and postembryonic recurrent pregnancy loss. Blood Coagulation & Fibrinolysis, 2009. 20(2): p. 134–140.10.1097/MBC.0b013e32832545f3Search in Google Scholar

18. GONÇALVES, R.O., L.R. FRAGA, W.V.B. SANTOS, A.F.L.D. CARVALHO, B.A.V. CERQUEIRA, M.A.C. SARNO, et al., Association between the thrombophilic polymorphisms MTHFR C677T, Factor V Leiden, and prothrombin G20210A and recurrent miscarriage in Brazilian women. 2016.10.4238/gmr.15038156Search in Google Scholar

19. SERGI, C., T. AL JISHI, and M. WALKER, Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association. Archives of gynecology and obstetrics, 2015. 291(3): p. 671–679.10.1007/s00404-014-3443-xSearch in Google Scholar

20. WRAMSBY, M., M. STEN-LINDER, and K. BREMME, Primary habitual abortions are associated with high frequency of factor V Leiden mutation. Fertility and sterility, 2000. 74(5): p. 987–991.10.1016/S0015-0282(00)01545-4Search in Google Scholar

21. COULAM, C.B., D. WALLIS, J. WEINSTEIN, D.S. DASGUPTA, and R.S. JEYENDRAN, Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. American Journal of Reproductive Immunology, 2008. 60(5): p. 426–431.10.1111/j.1600-0897.2008.00640.x18803625Search in Google Scholar

22. SIMONE, B., V. DE STEFANO, E. LEONCINI, J. ZACHO, I. MARTINELLI, J. EMMERICH, et al., Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. 2013, Springer.10.1007/s10654-013-9825-8393523723900608Search in Google Scholar

23. SILAN, F., I. MOSSE, A. GONCHAR, N. SEDLYAR, A.V. KILCHEVSKY, O. YILDIZ, et al., Comparison of the thrombophilic gene polymorphisms and recurrent pregnancy loss: Results on combined gene effect of FV Leiden, FVR2, FXIII, MTHFR (A1298C and C677T), PAI-1 4G/5G and ACE I/D genes in RPL Women from Misk/Belarus and Canakkale-Sivas/Turkey. Biomedical Genetics and Genomics, 2016. 1(4): p. 87–93.10.15761/BGG.1000117Search in Google Scholar

24. EMMERICH, J., F.R. ROSENDAAL, M. CATTANEO, M. MARGAGLIONE, V. DE STEFANO, T. CUMMING, et al., Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism. Thrombosis and haemostasis, 2001. 86(09): p. 809–816.10.1055/s-0037-1616136Search in Google Scholar

25. GOODMAN, C., J. HUR, C.S. GOODMAN, R.S. JEYENDRAN, and C. COULAM, Are polymorphisms in the ACE and PAI-1 genes associated with recurrent spontaneous miscarriages? American Journal of Reproductive Immunology, 2009. 62(6): p. 365–370.Search in Google Scholar

26. SAHIN, U. and M. OZCAN, The End of a Long Debate: Methylenetetrahydrofolate Reductase Gene Polymorphisms do not Increase Thrombosis Risk. The Eurasian journal of medicine, 2017. 49(1): p. 76.10.5152/eurasianjmed.2017.16080538950428416942Search in Google Scholar

27. KARCZEWSKI, K.J., L.C. FRANCIOLI, G. TIAO, B.B. CUMMINGS, J. ALFÖLDI, Q. WANG, et al., Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. BioRxiv, 2019: p. 531210.Search in Google Scholar

28. ZARROUK, M., S. SALIM, J. ELF, A. GOTTSÄTER, and S. ACOSTA, Testing for thrombophilia in mesenteric venous thrombosis–Retrospective original study and systematic review. Best Practice & Research Clinical Gastroenterology, 2017. 31(1): p. 39–48.10.1016/j.bpg.2016.11.00228395787Search in Google Scholar

29. HWANG, K.R., Y.M. CHOI, J.J. KIM, S.K. LEE, K.M. YANG, E.C. PAIK, et al., Methylenetetrahydrofolate reductase polymorphisms and risk of recurrent pregnancy loss: A case-control study. Journal of Korean medical science, 2017. 32(12): p. 2029–2034.10.3346/jkms.2017.32.12.2029568050429115087Search in Google Scholar

30. ELGARI, M.M., N.A. IBRAHIM, A.R.M. MUDDATHIR, F.M. ELTOOM, and I.M. IBRAHIM, Frequency of thrombophilic gene mutations in patients with deep vein thrombosis and in women with recurrent pregnancy loss. Open Life Sciences, 2017. 12(1): p. 162–166.10.1515/biol-2017-0019Search in Google Scholar

31. PETRILLI, C.M., L. HEIDEMANN, M. MACK, P. DURANCE, and V. CHOPRA, Inpatient inherited thrombophilia testing. 2016.10.1002/jhm.261627782379Search in Google Scholar

32. ADLER, G., E. MAHMUTBEGOVIC, A. VALJEVAC, M.A. ADLER, N. MAHMUTBEGOVIC, K. SAFRANOW, et al., Association between-675 ID, 4G/5G PAI-1 gene polymorphism and pregnancy loss: A systematic review. Acta Informatica Medica, 2018. 26(3): p. 156.10.5455/aim.2018.26.156-159619540030515004Search in Google Scholar

33. MIDDELDORP, S., Inherited thrombophilia: a double-edged sword. ASH Education Program Book, 2016. 2016(1): p. 1–9.10.1182/asheducation-2016.1.1614248827913455Search in Google Scholar

34. KUDO, M., H.L. LEE, I.A. YANG, and P.J. MASEL, Utility of thrombophilia testing in patients with venous thrombo-embolism. Journal of thoracic disease, 2016. 8(12): p. 3697.10.21037/jtd.2016.12.40522720028149566Search in Google Scholar

35. ZÖLLER, B., O. MELANDER, P.J. SVENSSON, and G. ENGSTRÖM, Factor V Leiden paradox in a middle-aged Swedish population: A prospective study. Vascular Medicine, 2018. 23(1): p. 52–59.10.1177/1358863X1774559129320959Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo